Pieter A Van Zwieten

Title: The Innovations of Pieter A Van Zwieten

Introduction

Pieter A Van Zwieten is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of glaucoma. His innovative approach has led to the development of a unique pharmaceutical composition that addresses this eye condition.

Latest Patents

Pieter A Van Zwieten holds a patent for a pharmaceutical composition for the treatment of glaucoma. The method involves using compounds of a specific formula, wherein R1 can be hydrogen, alkyl of 1 to 4 carbon atoms, hydroxy-(alkyl of 1 to 4 carbon atoms), benzyl, halo-benzyl, methyl-benzyl, methoxy-benzyl, or allyl. This patent represents a significant advancement in glaucoma treatment, showcasing his expertise in pharmaceutical innovation. He has 1 patent to his name.

Career Highlights

Pieter A Van Zwieten is associated with Karl Thomae Gesellschaft mit beschränkter Haftung, a company known for its focus on pharmaceutical development. His work at this organization has allowed him to explore and implement innovative solutions in the medical field. His dedication to research and development has positioned him as a key figure in his area of expertise.

Collaborations

Throughout his career, Pieter has collaborated with esteemed colleagues such as Hendricus C Innemee and Jacobus C Van Meel. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.

Conclusion

Pieter A Van Zwieten's contributions to the field of glaucoma treatment through his innovative patent highlight his role as a significant inventor in the pharmaceutical industry. His work continues to impact the lives of those affected by this condition, showcasing the importance of innovation in healthcare.